Dana dhuwit saben saham BrainsWay Ltd (BWAY)

Simbol lan logo merek BrainsWay (BWAY)

BrainsWay Ltd. (BWAY) leads the non-invasive neurostimulation sector, offering drug-free therapy for depression. Equipment transportation complexities create current operational challenges, although the annual trend of cash per share mitigates these risks. The value of 1.57 represents the current level of the metric. Unique patents for helmet design and an extensive clinic network ensure the long-term sustainability of business margins.

BWAY: Dhuwit awis saben saham BrainsWay 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis BrainsWay Ltd. (BWAY)

- rega saham lan prakiraan rega para ahli:
- data dhuwit lan arus kas:
Analisis umum perusahaan:BWAY BrainsWay
Produk asil prodhuksi BrainsWay Limited

For the R&D-intensive business of BrainsWay Ltd. (BWAY) focused on creating magnetic brain stimulation systems, cash per share serves as an indicator of the company's ability to retain highly qualified neuropsychiatrists and engineers. This metric is calculated by dividing total liquid assets by the number of shares outstanding, allowing investors to assess the company's actual margin of safety and the efficiency of capital management amidst innovative development.